Stocktoria
Armata Pharmaceuticals, Inc. ARMP
NYSE American · XASE · stock · Biological Products, (No Diagnostic Substances) · website · IPO 1994-05-20
Armata Pharmaceuticals, Inc. statistics & valuation
Market cap$237.2M
Market cap as of 2026-06-30. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on assets | -226.1% | -21.9% | -70.2% | -38.5% | -33.2% | -56.1% | -76.5% | -114.8% | -115.3% | -103.8% |
| Return on equity | 79.5% | 39.4% | 215.3% | -102.3% | -91.2% | -117.6% | -133.5% | -217.1% | -52.7% | -193.7% |
| Current ratio | 1.19 | 0.23 | 1.16 | 1.09 | 3.11 | 1.62 | 1.36 | 5.10 | 2.74 | 1.78 |
Source: SEC EDGAR filings · CIK 0000921114 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.